-
Mashup Score: 38EASD and ISPAD join forces for a new position statement: How to use AID systems around exercise in type 1 diabetes - 13 day(s) ago
Physical activity poses many challenges to people living with type 1 diabetes. A recently published position statement offers practical recommendations for the use of automated insulin delivery (AID) systems around planned and unplanned exercise, introducing five key strategies and a detailed assessment of curr ently available AID systems. Managing blood glucose levels and physical activity is one of the biggest daily challenges for people with type 1 diabetes (T1D). For users of automated insulin
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 14ISPAD 2024: For the 50th anniversary, a paradigm shift in how diabetes in children should be managed - 2 month(s) ago
In 1974, the International Society for Pediatric and Adolescent Diabetes (ISPAD) was founded as a professional organisation to promote science, research, education and advocacy in childhood and adolescent diabetes. 50 years later, the Annual ISPAD Conference 2024 reflected the fundamental changes in the ways type 1 diabetes is perceived and treated today. The 50th conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) was held from the 16th to 19th of October 2024, in
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
A paradigm shift in pediatric diabetescare to tackle #T1D which is now perceived as a disease that is evolving in stages. Look up our conference wrap up #ISPAD2024 and the full insights from Prof. Limbert and Prof. Hofer here: https://t.co/wdfXZnnwxg https://t.co/e0ts1zTmjZ
-
-
Mashup Score: 15
In a recent randomised controlled trial, a whole-food, plant-based diet and exercise intervention was superior to standard medical care in improving glycaemic control, promoted diabetes remission and reduced the need for medication. The results illustrate the potential of lifestyle changes that are often overlooked in favour of medical interventions. âNutrition is the single most important lifestyle fa ctor in preventing, treating, managing and reversing type 2 diabetes,â says John H. Kelly Jr., principal
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
A recent study published in @DiabetologiaJnl found that a whole-food, #PlantBased diet combined with exercise improved glycaemic control and reduced the need for medication in adults with #type2diabetes. Read more: https://t.co/7eJKHEI6jL https://t.co/Lk4eilpfLs
-
-
Mashup Score: 11After 15 years: EASD and other societies present updated recommendations on how to manage hyperglycaemic crises in adults - 3 month(s) ago
A new consensus report offers key insights from over 6,000 articles on diabetic ketoacidosis and hyperglycaemic hyperosmolar state published since the previous 2009 consensus statement. Here we summarise how the evolving knowledge impacts clinical practice.. âThe number of patients with hyperglycaemic crises has increased worldwide,â says Guillermo E. Umpierrez, lead author of a new consensus report that was simultaneously published in Diabetologia and Diabetes Care. In both type 1 and type 2 diabetes,
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
EASD on a joint effort with other societies have updated the 2009 Consensus Statement on Hyperglycaemic Crises in Adults Patients With #diabetes . Check out whatâs new in diagnosis and treatment of DKA and HHS on EASD e-Learning: https://t.co/HN4A21xKAr https://t.co/DMUc7Gff5I
-
-
Mashup Score: 0ESC 2024: How diabetologists and cardiologists are paving the way for precision medicine - 3 month(s) ago
Cardiologists are increasingly interested in advances in diabetology, especially the latest drug classes, reports Tina Vilsbøll from a joint session of the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) a t this yearâs ESC Congress. She advocates for a multidisciplinary approach, with the patient at the centre of care. To kick off the autumn conference season, London hosted the ESC Congress, the worldâs largest cardiology meeting, with over 30,000
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
âWe are discussing the same peptides and the same patients,â @TinaVils comments on the joint EASD/ESC session at the #ESC2024 of the @ESCardio. Today, multidisciplinary approaches are paving the way for precision medicine. Full video: https://t.co/azv8BIB1wQ https://t.co/jPFnGgOZZL
-
-
Mashup Score: 6SLENDO 2024: Transcontinental Collaboration - 3 month(s) ago
The global burden of diabetes is continually growing, which calls for enhanced collective action to prevent and treat diabetes complications. The Sri Lanka College of Endocrinology, the European Association for the Study of Diabetes and the International Society of Endocrinology joined forces at the Sri Lanka Endocrine Congress (SLENDO) 2024 to promote excellence in diabetes care and research. SLENDO 2024 was held from 8th to 11th August, 2024, in Colombo, Sri Lanka, and was organised by the Sri Lanka
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
How do #SGLT2Inhibitors provide cardiometabolic and renal benefits, thus prompting major shifts in the management of a wide range of patients? @CatConte_MD discussed the development and mechanisms of effects of #SGLT2Inhibitors at #SLENDO2024. Watch here:https://t.co/kWxIpGCdNj https://t.co/x7w6oAwSnZ
-
-
Mashup Score: 6GLP-1 receptor agonists improve kidney outcomes â and they do so independently of SGLT2 inhibitors - 4 month(s) ago
The FLOW trial brought GLP-1 receptor agonists (GLP-1 RAs) to the forefront of the discussion about chronic kidney disease and type 2 diabetes. A new subanalysis n ow sheds light on the concomitant use of GLP-1 RAs and SGLT2 inhibitors. In May 2024, results were published from the FLOW trial, the first-ever dedicated renal outcomes study of a GLP-1 RA (semaglutide) in people living with type 2 diabetes (T2D) and chronic kidney disease (CKD). âThe primary outcome was strikingly positive, with a 24 %
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
New insights into #CKD and #T2D! A subanalysis of the FLOW study by PI @KatherineTuttl8 finds that the benefits of GLP-1 RA are independent of SGLT2i use. Could this lead to a clinical guideline update? Read more:https://t.co/PNSgIjRHJ2 https://t.co/Z0K5VQao1F
-
-
Mashup Score: 22
The recently published Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD) was a joint effort of the European Association for the Study of the Liver (EASL), the European Association for the Study of Diabetes (EASD) and the Europea n Association for the Study of Obesity (EASO). It not only introduces a new name, but also states key recommendations on screening, diagnosis, and treatment. Here we provide an overview with a particular focus on the implications for
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
New guideline redefines #NAFLD as #MASLD, focusing on links to #type2diabetes and #obesity. Read more about the latest recommendations: https://t.co/Z44nEsKxI8 @EASDnews @EASLnews @EASOobesity https://t.co/RWcVOlJobD
-
-
Mashup Score: 21Horizons â EASD e-Learning - 6 month(s) ago
Professors Chantal Mathieu and Tina Vilsbøll provide a summary of some key presentations, posters, plenaries, and debates presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2023. Read more. Two experts, two takes, one hot topic Top diabetes researchersâ top 5 research questions.
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
The EASD e-Learning Newsflash is back from the #ADASciSessions! Day 1 highlights include the Updates of Standards of Care with @nuhaaelsayed, a look into MASLD with Michael Roden, and key findings from the SURMOUNT OSA by Francesco Giorgino. Watch here: https://t.co/gdtp3qS5xj https://t.co/b3nbKEhuuy
-
-
Mashup Score: 21Horizons â EASD e-Learning - 6 month(s) ago
Professors Chantal Mathieu and Tina Vilsbøll provide a summary of some key presentations, posters, plenaries, and debates presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2023. Read more. Two experts, two takes, one hot topic Top diabetes researchersâ top 5 research questions.
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet-
The EASD e-Learning Newsflash is back from the #ADASciSessions! Day 1 highlights include the Updates of Standards of Care with @nuhaaelsayed, a look into MASLD with Michael Roden, and key findings from the SURMOUNT OSA by Francesco Giorgino. Watch here: https://t.co/gdtp3qS5xj https://t.co/b3nbKEhuuy
-
New position statement from @EASDnews & @ispad_org offering tailored strategies for #AID users to balance exercise and blood glucose in #T1D. đââď¸đđ´ââď¸ đRead more about key recommendations making #exercise management more predictable and safe: https://t.co/bjqTUO91SI #diabetes https://t.co/PcSHVpYdCF